Status:

TERMINATED

Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection

Lead Sponsor:

AHS Cancer Control Alberta

Conditions:

Breast Neoplasms

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Breast cancer affects many women. One of the places to which it can spread is the lymph glands under the arm. The type of treatment offered to patients often will depend on whether those lymph glands ...

Detailed Description

1.0 Introduction Breast cancer is the most common cancer in North American women. It is estimated that one in 8 American women will develop breast cancer during her lifetime. Surgical treatment has e...

Eligibility Criteria

Inclusion

  • Male or female. If female of child bearing potential and outside of the window of 10 days since the last menstrual period, a negative pregnancy test.
  • Biopsy proven breast carcinoma (core biopsy or fine needle aspiration, although core biopsies are preferred.)
  • Tumour size T1-3, N0 clinically
  • All patients will have pre-operative mammography +/- ultrasound of the breast
  • Age equal to or greater than 18 years
  • Able and willing to follow instructions and comply with the protocol
  • Provide written informed consent prior to participation in this study

Exclusion

  • Nursing or pregnant females
  • Previous malignancy or diagnosis less than 10 (ten) years ago. Skin cancers (excluding malignant melanoma) and carcinoma in situ of the cervix are exceptions.
  • Excisional biopsy of the tumour has been performed
  • Age less than 18 years
  • Patient has diabetes

Key Trial Info

Start Date :

June 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2007

Estimated Enrollment :

199 Patients enrolled

Trial Details

Trial ID

NCT00123799

Start Date

June 1 2004

End Date

April 1 2007

Last Update

June 21 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cross Cancer Institute

Edmonton, Alberta, Canada, T6G 1Z2